121 related articles for article (PubMed ID: 8709094)
21. Enhanced efficacy of combinations of retinoic acid- and retinoid X receptor-selective retinoids and alpha-interferon in inhibition of cervical carcinoma cell proliferation.
Lotan R; Dawson MI; Zou CC; Jong L; Lotan D; Zou CP
Cancer Res; 1995 Jan; 55(2):232-6. PubMed ID: 7812950
[TBL] [Abstract][Full Text] [Related]
22. Synthetic retinoids and their nuclear receptors.
Dawson MI
Curr Med Chem Anticancer Agents; 2004 May; 4(3):199-230. PubMed ID: 15134501
[TBL] [Abstract][Full Text] [Related]
23. Apoptosis induction in cancer cells by a novel analogue of 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid lacking retinoid receptor transcriptional activation activity.
Dawson MI; Hobbs PD; Peterson VJ; Leid M; Lange CW; Feng KC; Chen Gq ; Gu J; Li H; Kolluri SK; Zhang Xk ; Zhang Y; Fontana JA
Cancer Res; 2001 Jun; 61(12):4723-30. PubMed ID: 11406543
[TBL] [Abstract][Full Text] [Related]
24. sp2-bridged diaryl retinoids: effects of bridge-region substitution on retinoid X receptor (RXR) selectivity.
Dawson MI; Hobbs PD; Jong L; Xiao D; Chao WR; Pan C; Zhang XK
Bioorg Med Chem Lett; 2000 Jun; 10(12):1307-10. PubMed ID: 10890152
[TBL] [Abstract][Full Text] [Related]
25. Modulation of retinoic acid receptor function alters the growth inhibitory response of oral SCC cells to retinoids.
Le Q; Dawson MI; Soprano DR; Soprano KJ
Oncogene; 2000 Mar; 19(11):1457-65. PubMed ID: 10723137
[TBL] [Abstract][Full Text] [Related]
26. Differential modulation of rat hepatic stellate phenotype by natural and synthetic retinoids.
Hellemans K; Verbuyst P; Quartier E; Schuit F; Rombouts K; Chandraratna RA; Schuppan D; Geerts A
Hepatology; 2004 Jan; 39(1):97-108. PubMed ID: 14752828
[TBL] [Abstract][Full Text] [Related]
27. Regulation of hepatic lecithin:retinol acyltransferase activity by retinoic acid receptor-selective retinoids.
Shimada T; Ross AC; Muccio DD; Brouillette WJ; Shealy YF
Arch Biochem Biophys; 1997 Aug; 344(1):220-7. PubMed ID: 9244401
[TBL] [Abstract][Full Text] [Related]
28. Retinoids and malignant melanoma: a pathway of proliferation inhibition on SK MEL28 cell line.
Emionite L; Galmozzi F; Raffo P; Vergani L; Toma S
Anticancer Res; 2003; 23(1A):13-9. PubMed ID: 12680189
[TBL] [Abstract][Full Text] [Related]
29. RAR agonists stimulate SOX9 gene expression in breast cancer cell lines: evidence for a role in retinoid-mediated growth inhibition.
Afonja O; Raaka BM; Huang A; Das S; Zhao X; Helmer E; Juste D; Samuels HH
Oncogene; 2002 Nov; 21(51):7850-60. PubMed ID: 12420222
[TBL] [Abstract][Full Text] [Related]
30. Heterocycle-containing retinoids. Discovery of a novel isoxazole arotinoid possessing potent apoptotic activity in multidrug and drug-induced apoptosis-resistant cells.
Simoni D; Roberti M; Invidiata FP; Rondanin R; Baruchello R; Malagutti C; Mazzali A; Rossi M; Grimaudo S; Capone F; Dusonchet L; Meli M; Raimondi MV; Landino M; D'Alessandro N; Tolomeo M; Arindam D; Lu S; Benbrook DM
J Med Chem; 2001 Jul; 44(14):2308-18. PubMed ID: 11428925
[TBL] [Abstract][Full Text] [Related]
31. Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cells.
Chen Y; Dokmanovic M; Stein WD; Ardecky RJ; Roninson IB
Cancer Res; 2006 Sep; 66(17):8749-61. PubMed ID: 16951191
[TBL] [Abstract][Full Text] [Related]
32. The effects of RARalpha and RXRalpha proteins on growth, viability, and differentiation of v-myb-transformed monoblasts.
Vodicka P; Sevcíková S; Smardová J; Soucek K; Smarda J
Blood Cells Mol Dis; 2000 Aug; 26(4):395-406. PubMed ID: 11042040
[TBL] [Abstract][Full Text] [Related]
33. Retinoic acid receptor- and retinoid X receptor-selective retinoids activate signaling pathways that converge on AP-1 and inhibit squamous differentiation in human bronchial epithelial cells.
Lee HY; Dawson MI; Walsh GL; Nesbitt JC; Eckert RL; Fuchs E; Hong WK; Lotan R; Kurie JM
Cell Growth Differ; 1996 Aug; 7(8):997-1004. PubMed ID: 8853895
[TBL] [Abstract][Full Text] [Related]
34. The role of specific retinoid receptors in sebocyte growth and differentiation in culture.
Kim MJ; Ciletti N; Michel S; Reichert U; Rosenfield RL
J Invest Dermatol; 2000 Feb; 114(2):349-53. PubMed ID: 10651997
[TBL] [Abstract][Full Text] [Related]
35. Synergistic cytotoxicity exhibited by combination treatment of selective retinoid ligands with taxol (Paclitaxel).
Vivat-Hannah V; You D; Rizzo C; Daris JP; Lapointe P; Zusi FC; Marinier A; Lorenzi MV; Gottardis MM
Cancer Res; 2001 Dec; 61(24):8703-11. PubMed ID: 11751388
[TBL] [Abstract][Full Text] [Related]
36. Retinoic acid receptor alpha and retinoid-X receptor-specific agonists synergistically target telomerase expression and induce tumor cell death.
Pendino F; Dudognon C; Delhommeau F; Sahraoui T; Flexor M; Bennaceur-Griscelli A; Lanotte M; Ségal-Bendirdjian E
Oncogene; 2003 Dec; 22(57):9142-50. PubMed ID: 14668795
[TBL] [Abstract][Full Text] [Related]
37. Increased retinoic acid responsiveness in lung carcinoma cells that are nonresponsive despite the presence of endogenous retinoic acid receptor (RAR) beta by expression of exogenous retinoid receptors retinoid X receptor alpha, RAR alpha, and RAR gamma.
Wan H; Hong WK; Lotan R
Cancer Res; 2001 Jan; 61(2):556-64. PubMed ID: 11212249
[TBL] [Abstract][Full Text] [Related]
38. Differential responses of normal, premalignant, and malignant human bronchial epithelial cells to receptor-selective retinoids.
Sun SY; Kurie JM; Yue P; Dawson MI; Shroot B; Chandraratna RA; Hong WK; Lotan R
Clin Cancer Res; 1999 Feb; 5(2):431-7. PubMed ID: 10037194
[TBL] [Abstract][Full Text] [Related]
39. Suppression of squamous cell carcinoma growth and differentiation by retinoids.
Lotan R
Cancer Res; 1994 Apr; 54(7 Suppl):1987s-1990s. PubMed ID: 8137325
[TBL] [Abstract][Full Text] [Related]
40. Identification and functional separation of retinoic acid receptor neutral antagonists and inverse agonists.
Klein ES; Pino ME; Johnson AT; Davies PJ; Nagpal S; Thacher SM; Krasinski G; Chandraratna RA
J Biol Chem; 1996 Sep; 271(37):22692-6. PubMed ID: 8798442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
